A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease

PHASE2

Phase

COMPLETED

Status

349

Enrollment

INDUSTRY

Sponsor class

Conditions

DRUG: SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium Phosphate)
DRUG: Mycophenolic Acid 0.1%
DRUG: Mycophenolic Acid 0.3%
DRUG: Betamethasone Sodium Phosphate 0.01%
DRUG: Placebo Comparator: Vehicle
DRUG: Cyclosporine 0.05% Ophthalmic Emulsion
DRUG: Lifitegrast 5% Ophthalmic Solution

Surface Ophthalmics, Inc.